DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1Apicore Pharmaceuticals Private Limited
03 1Apicore US LLC
04 1Ash Stevens LLC
05 1BSP Pharmaceuticals S.p.A.
06 1Cilag AG
07 1Hetero Labs Limited
08 1Hubei Honch Pharmaceutical Co., Ltd.
09 1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
10 1Laurus Labs Limited
11 1MSN Laboratories Private Limited
12 1NATCO PHARMA LIMITED
13 1Qilu Pharmaceutical Co. Ltd.
14 1SHILPA PHARMA LIFESCIENCES LIMITED
15 1SciAnda (Changshu) Pharmaceuticals, Ltd.
16 2ScinoPharm Taiwan Ltd.
17 1Sionc Pharmaceutical Private Limited
18 1TAPI Czech Industries s.r.o.
19 1Teva Czech Industries s.r.o
01 3BORTEZOMIB
02 15Bortezomib
03 1Bortezomib 3.5mg/vial
04 1bortezomib
01 3China
02 9India
03 1Israel
04 1Italy
05 1Switzerland
06 3Taiwan
07 1U.S.A
08 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-922
Start Marketing Date : 2012-07-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14096-140
Start Marketing Date : 2009-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42973-140
Start Marketing Date : 2009-11-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48957-0018
Start Marketing Date : 2003-05-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 43624-024
Start Marketing Date : 2003-05-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (3.5mg/3.5mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 12502-5268
Start Marketing Date : 2010-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42385-716
Start Marketing Date : 2012-12-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0011
Start Marketing Date : 2012-01-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54245-7004
Start Marketing Date : 2013-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47848-031
Start Marketing Date : 2014-09-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
24
PharmaCompass offers a list of Bortezomib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bortezomib manufacturer or Bortezomib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bortezomib manufacturer or Bortezomib supplier.
PharmaCompass also assists you with knowing the Bortezomib API Price utilized in the formulation of products. Bortezomib API Price is not always fixed or binding as the Bortezomib Price is obtained through a variety of data sources. The Bortezomib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DPBA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DPBA, including repackagers and relabelers. The FDA regulates DPBA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DPBA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DPBA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DPBA supplier is an individual or a company that provides DPBA active pharmaceutical ingredient (API) or DPBA finished formulations upon request. The DPBA suppliers may include DPBA API manufacturers, exporters, distributors and traders.
click here to find a list of DPBA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DPBA as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for DPBA API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture DPBA as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain DPBA and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DPBA NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of DPBA suppliers with NDC on PharmaCompass.
We have 16 companies offering DPBA
Get in contact with the supplier of your choice:
